Venom from the parasitoid wasp Nasonia vitripennis dramatically elevates sorbitol 13 levels in its natural fly hosts. In humans, sorbitol elevation is associated with 14 complications of diabetes. Here we demonstrate that venom also induces this 15 disease-relevant phenotype in human cells, and investigate possible pathways 16 involved. Key findings are that (a) low doses of Nasonia venom elevate sorbitol 17 levels in human renal mesangial cells (HRMCs) without changing glucose or 18 fructose levels; (b) venom is a much more potent inducer of sorbitol elevation than 19 glucose; (c) low venom doses significantly alter expression of genes involved in 20 sterol and alcohol metabolism, transcriptional regulation, and chemical/stimulus 21 response; (d) although venom treatment does not alter expression of the key 22 sorbitol pathway gene aldose reductase (AR); (e) venom elevates expression of a 23 related gene implicated in diabetes complications (AKR1C3) as well as the 24 fructose metabolic gene (GFPT2). Although elevated sorbitol is accepted as a 25
INTRODUCTION

32
Venom from the parasitoid wasp Nasonia vitripennis causes significant sorbitol 33 accumulation in insect hosts without altering glucose level (1) . Few studies have 34 examined the conservation of parasitoid venom phenotypes in a human disease relevant 35 model (2). Elevated sorbitol is believed to be a major contributing factor to secondary 36 complications of diabetes (3), particularly kidney disease, which is a leading cause of 37 morbidity and mortality in diabetics (4). However, the mechanism of sorbitol pathway 38 regulation in the human kidney and relative contribution to glucose-induced damage is 39 not well understood. Here we demonstrate conservation of this significant Nasonia 40 venom phenotype in human cells and present a novel approach to study effects of 41 sorbitol elevation in vitro, independent of glucose elevation. 5 induce elevation of sorbitol in primary human renal mesangial cells (HRMCs) from the 79 glomerulus. We then compare this induction to high glucose treatment alone to assess 80 relative efficacy of venom and glucose to elevate sorbitol. We also investigate whether 81 venom induces targeted gene expression changes prior to sorbitol accumulation as a 82 method of identifying potentially causative genes. Finally, we use computational 83 methods to determine the relative binding affinity for glucose of the canonical (AR) and 84 other candidate AKR enzymes. This study reveals a conserved venom function (sorbitol 85 elevation) across vastly divergent species (S. bullata and H. sapiens) and provides a first 86 step to evaluating additional candidate genes for regulating sorbitol metabolism in 87 human cells.
88
MATERIAL AND METHODS 89 2.1 Cell culture system: Human renal mesangial cells (HRMCs) were chosen because 90 of their high rate of metabolic activity, as well as their important roles in regulating blood 91 flow in the kidney and in the pathophysiology of diabetic nephropathy (30, 31) . Within 92 the kidney, these cells are located in close apposition to the glomerular arterioles and 93 therefore are exposed to circulating levels of glucose in the blood. Primary HRMCs 94 (designated P1 in our lab) were purchased from ScienCell and cultured according to the 95 published protocol (30-32). Cells were expanded in culture to P3 and then stored in 
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For NGS data processing, raw 50 bp reads were de-multiplexed using configure 
185
RESULTS
186
High venom doses are associated with growth inhibition and cell toxicity. We first 187 assessed the effects of different venom doses on HRMC growth and morphology, 
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To avoid complications of cell pathology at the high doses, we concentrated our next 206 analyses on lower venom doses (1/128 to 1 VRE). 
214
(1/128 VRE -9.6 x 10 -2 mg per mL). Significant increases were found at 1/128, 1/16, 11 cells from Homo sapiens. This phenotype coincides with an apparent absence of cell 221 growth inhibition or visible signs of apoptosis. The finding suggests that the mechanism 222 of venom-induced sorbitol accumulation is likely conserved, and therefore represents an 223 important potential target for understanding sorbitol pathway regulation.
224
Venom is a strong inducer of sorbitol elevation compared to glucose. To 225 compared the venom phenotype to glucose-mediated sorbitol elevation, we also 226 incubated HRMCs with escalating glucose concentrations and then assayed intracellular 227 sorbitol levels at 24 hours. There is a significant elevation of sorbitol at the highest 228 glucose concentrations of 110 mM and 220 mM (19.8 -39.6 g/L) as compared to 229 controls in standard culture media (n=4 per glucose concentration; 2-tailed student's t-230 test p<0.05 for 110 and 220 mM, and not significant for 11, 25, and 55 mM) ( Figure 3) .
231
Yet, peak glucose-induced sorbitol elevation was less than half that observed with low 
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MT-RNR2-like 1 is the most significantly differentially expressed gene in this overlapping 283 set. It is a mitochondrial-derived nuclear gene with sequence homology to Humanin 1.
284
Humanin and its derivatives have been implicated in protection against oxidative stress 285 mediated by superoxide dismutase (50, 51). Low dose venom causes between a -9.11 286 to -9.26 log2-fold decrease in expression of this gene at 4 hours, and this gene has the 287 highest DE rank across all sorbitol-elevating doses of venom. (Table S3 ). All differentially 295 expressed genes show a marked reduction in the magnitude of the fold change at 24 296 hours as compared to 4 hours. Gene ontology analysis of the full set of 47 genes again 297 shows significant enrichment for alcohol and steroid metabolism, and hormone response 298 (Table S3 ).
299
The broad pattern of change is similar to our previous findings of venom-induced 
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We therefore investigated sorbitol pathway gene expression changes that precede this 308 elevation, for known and suspected genes involved in sorbitol metabolism (53). Neither 
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AKR1C3 belongs to the same protein family as AR but is not recognized as a sorbitol 319 pathway gene. However, the gene has previously been identified amongst the top 50 
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Based on the RNASeq results, AKR1C3 is a potential candidate for involvement in 329 sorbitol synthesis. To investigate the likelihood of enzyme interaction with sorbitol 330 pathway substrates, we estimated relative binding affinity (K m ) of candidate sorbitol 331 pathway AKRs from humans, using in silico modeling of docking potential for glucose 332 with NADPH cofactor bound. Docking potential is the predicted affinity of small 333 molecules, in this case glucose, for a receptor of known or predicted 3-dimensional 334 structure (48, 49). The more negative the estimate produced by iGemDocks, the greater 335 the predicted binding affinity for the target substrate. Three AKR1C* sub-family 336 enzymes (1C1, 1C2, 1C3) exhibited greater relative binding affinity for glucose than did transcriptional mechanism to alter sorbitol metabolism in HRMCs under normoglycemic 363 conditions.
364
Nasonia venom significantly elevates sorbitol in human renal cells in culture without 365 altering levels of glucose or fructose. We examined gene expression changes occurring 366 at 4 hours, 20 hours prior to the elevated sorbitol phenotype, to identify a putative 367 mechanism. We focused our attention on the AKRs that have been implicated in sorbitol 368 metabolism and/or diabetic nephropathy (59). One of these genes (AR) has traditionally 369 been annotated as encoding the primary sorbitol-synthesizing enzyme. Although AR 370 was not responsive to venom another related enzyme, AKR1C3, was significantly 371 upregulated in response to low venom doses. AKR1C3 has been implicated in the 372 pathophysiology of diabetic nephropathy -although no mechanism has been proposed 373 (54).
374
Protein structural prediction and glucose docking reveal that AKR1C* enzymes have a 
